PASTEUR Act Action Alert

You must enable cookies for this web site to function properly.

It is estimated that more than 2.8 million antibiotic-resistant infections occur in the United States each year, and at least 35,000 people die as a result. The bipartisan Pioneering Antimicrobial Subscriptions to End Upsurging Resistance Act better known as the PASTEUR Act will establish a program to develop antimicrobial innovations targeting the most challenging pathogens and most threatening infections.

Under the PASTEUR Act (H.R. 8920 and S. 4760), the federal government would create market incentives for the development of lifesaving antimicrobial drugs.

The CF community knows the challenges of antimicrobial resistance. Resistant pathogens are a key cause of lung function decline and respiratory failure. The PASTEUR Act is bipartisan and bicameral. Antibiotic resistance impacts all of us. Thank you for raising your voice!

To see if your Congressmember has already expressed support, click here.
To see if your Senator has already expressed support, click here.

Recipients

Your Senators
Your Representative

Contact

*Required fields

* Title:

* First Name:

* Last Name:

* Your Email:

* Address 1:

Address 2:

* City:

* State / Province:

* ZIP / Postal Code:

* Phone Number:

1.	Question - Not Required - What is your connection to cystic fibrosis?
2.	Question - Not Required - What are the major issues facing those with CF in your state? (Maximum response 255 chars, approx. 5 rows of text)
3.	Question - Not Required - Do you use social media?

Remember me. What's this?

If you take action and have not already registered, you will receive periodic updates and communications from Cystic Fibrosis Research Institute

Message

PASTEUR Act Action Alert

Dear [Decision Maker],

I write to ask you to support the bipartisan Pioneering Antimicrobial Subscriptions to End Upsurging Resistance Act (H.R. 8920 / S. 4760) better known as the PASTEUR Act to establish a program to develop antimicrobial innovations targeting the most challenging pathogens and most threatening infections.

Antibiotic resistant pathogens are a major public health concern, and these pathogens affect those with CF in disproportionate numbers. According to the Centers for Disease Control, more than 2.8 million antibiotic-resistant infections occur in the United States each year, and at least 35,000 people die as a result.

By necessity, doctors usually prescribe new drugs only after older antimicrobials fail, so that new drugs are held as a necessary "last resort." As such, demand is smaller, leaving drug developers to assume high risk with little return (for example, the company Achaogen took 15 years and $1 billion to develop an antimicrobial, but less than 10 months after FDA approval the company declared bankruptcy).

The PASTEUR Act would create market incentives for the development of lifesaving antimicrobial drugs. The cystic fibrosis community knows the challenges of antimicrobial resistance. Resistant pathogens are a key cause of lung function decline and respiratory failure. I urge you to support this life saving legislation.

* Personalize your message

I wish you safety and health. Thank you for your leadership during these extraordinarily challenging times.

Best Regards,
[Your Name]
[Your Address]
[City, State ZIP]